​Oorja's goal is to develop groundbreaking therapies for cardiopulmonary and fibrotic disorders that target the underlying pathophysiology of disease.

By addressing key pathways, our medicines promote cellular repair, reverse and or remodel fibrotic tissue, going beyond symptom management to establish a new therapeutic standard of care.

Our success is driven by an experienced team with a proven track record in pulmonary drug development, commercialization, and high-value transactions.

Biotechnology

Health Care

Oorja Bio

Org chart

Teams

Offices

Similar companies